Clinical improvement following therapy for periodontitis: Association with a decrease in IL‑1 and IL‑6

  • Authors:
    • Cátia Reis
    • Alexandra Viana da Costa
    • João Tiago Guimarães
    • Diana  Tuna
    • Ana Cristina Braga
    • José Julio Pacheco
    • Fernando  A. Arosa
    • Filomena Salazar
    • Elsa Maria Cardoso
  • View Affiliations

  • Published online on: May 19, 2014     https://doi.org/10.3892/etm.2014.1724
  • Pages: 323-327
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Although a number of inflammatory cytokines have been shown to be associated with periodontal pathogenesis, it is important to investigate further whether these biomarkers are associated with the degree of success in nonsurgical treatment of chronic periodontitis. The aim of the present study was to quantify the total levels of interleukin (IL)‑1α, ‑1β, ‑6, ‑10 and tumour necrosis factor (TNF)‑α in gingival crevicular fluid (GCF) of chronic periodontitis patients prior to and following nonsurgical periodontal therapy. In total, 52 GCF samples from disease sites of patients with chronic periodontitis, prior to and following periodontal therapy, and ten non‑disease sites from non‑periodontitis subjects, were collected and cytokine concentrations were determined using a multiplex method. Periodontal parameters, including bleeding on probing, probing pocket depth and the clinical attachment level, in all the sites were recorded. Untreated disease sites exhibited higher cytokine levels in the GCF when compared with the non‑disease sites. Nonsurgical periodontal therapy resulted in a statistically significant decrease in the total levels of IL‑1α, ‑1β and ‑6 in the GCF, but not in IL‑10 or TNF‑α. The results support the hypothesis that proinflammatory cytokines, including IL‑1α, IL‑1β and IL‑6, are likely to be involved in the pathogenesis of periodontitis and are good markers to evaluate the success of nonsurgical therapy in disease sites of patients with periodontitis.
View References

Related Articles

Journal Cover

July-2014
Volume 8 Issue 1

Print ISSN: 1792-0981
Online ISSN:1792-1015

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Reis C, da Costa AV, Guimarães JT, Tuna D, Braga AC, Pacheco JJ, Arosa FA, Salazar F and Cardoso EM: Clinical improvement following therapy for periodontitis: Association with a decrease in IL‑1 and IL‑6. Exp Ther Med 8: 323-327, 2014.
APA
Reis, C., da Costa, A.V., Guimarães, J.T., Tuna, D., Braga, A.C., Pacheco, J.J. ... Cardoso, E.M. (2014). Clinical improvement following therapy for periodontitis: Association with a decrease in IL‑1 and IL‑6. Experimental and Therapeutic Medicine, 8, 323-327. https://doi.org/10.3892/etm.2014.1724
MLA
Reis, C., da Costa, A. V., Guimarães, J. T., Tuna, D., Braga, A. C., Pacheco, J. J., Arosa, F. A., Salazar, F., Cardoso, E. M."Clinical improvement following therapy for periodontitis: Association with a decrease in IL‑1 and IL‑6". Experimental and Therapeutic Medicine 8.1 (2014): 323-327.
Chicago
Reis, C., da Costa, A. V., Guimarães, J. T., Tuna, D., Braga, A. C., Pacheco, J. J., Arosa, F. A., Salazar, F., Cardoso, E. M."Clinical improvement following therapy for periodontitis: Association with a decrease in IL‑1 and IL‑6". Experimental and Therapeutic Medicine 8, no. 1 (2014): 323-327. https://doi.org/10.3892/etm.2014.1724